evocalcet: Clinical Trials

1 trial of evocalcet, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow evocalcet: new trials by email Literature Review of evocalcet trials Research Report on evocalcet

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
KHK7580 - Parathyroid Carcinoma, Primary Hyperparathyroidism
Phase 3CompletedKyowa Kirin Co., Ltd.182017-08-302021-05-27

Conditions studied

Hyperparathyroidism, Primary (1)  ·  Parathyroid Neoplasms (1)

Sponsors

Kyowa Kirin Co., Ltd. (1)

Countries

Japan (1)